Mirae is a London, UK-based provider of an AI-driven continuous care platform for autoimmune disease and other complex chronic conditions.
Mirae has raised €4.8M across 1 funding round from 1 investor, most recently a round in Jul 2026. Based in London, UK; active in Healthtech. Data as of 29 Jul 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-29 | Other | €4.8M |
| Oxford Science Enterprises |
| View deal → |
